Monopar Therapeutics Inc.MNPR
Close of Friday, October 23, 2026 · Monopar Therapeutics Inc. is trading below its Pivot, OnlyAlpha's long-term trend line.
Price
$70.65
vs its Pivot
-8.3%
OnlyAlpha Score
38
Trend
Below its Pivot
Last 12 months. Solid line: price. Dashed green: the Pivot.
Returns
| 1 month | Year to date | 1 year | 3 years / yr | 5 years / yr |
|---|---|---|---|---|
| -20.5% | +8.2% | -10.9% | — | — |
No dividend in the last 12 months.
Who runs and owns it
In these funds
Big investors that own it (latest 13F)
| RA Capital | 0.5% of holdings |
| OrbiMed | 0.3% of holdings |
Get MNPR in your free daily emailAfter every close: whether MNPR is above or below its Pivot, its OnlyAlpha Score, and any new buy or sell signal, along with the rest of your list.
Track MNPR free → Full Stock check
Track MNPR free → Full Stock check